|
|||||
|
|
The Novel CXCR4 Antagonist KRH-3955 Is an Orally Bioavailable and Extremely Potent Inhibitor of Human Immunodeficiency Virus Type 1 Infection: Comparative Studies with AMD3100 |
|
| Authors: | Tsutomu Murakami Sei Kumakura Toru Yamazaki Reiko Tanaka Makiko Hamatake Kazu Okuma Wei Huang Jonathan Toma Jun Komano Mikiro Yanaka Yuetsu Tanaka Naoki Yamamoto |
| Affiliation: | AIDS Research Center, National Institute of Infectious Diseases, Tokyo 162-8640,1. Biomedical Research Laboratories, Kureha Corporation, Tokyo 169-8503,2. Department of Immunology, Graduate School and Faculty of Medicine, University of the Ryukyus, Nakagami, Okinawa 903-0215, Japan,3. Monogram Biosciences, South San Francisco, California 940804. |
| Abstract: | |
| Keywords: | |